|
1
|
Recent advances in neonatal pharmacotherapy.
|
Ann Pharmacother
|
2006
|
1.38
|
|
2
|
Iontophoretic permselective property of human nail.
|
J Dermatol Sci
|
2007
|
0.97
|
|
3
|
Noninvasive transcutaneous sampling of glucose by electroporation.
|
J Diabetes Sci Technol
|
2008
|
0.95
|
|
4
|
Trans-ungual iontophoretic delivery of terbinafine.
|
J Pharm Sci
|
2009
|
0.91
|
|
5
|
Ungual and transungual drug delivery.
|
Drug Dev Ind Pharm
|
2011
|
0.89
|
|
6
|
Transcutaneous electroporation mediated delivery of doxepin-HPCD complex: a sustained release approach for treatment of postherpetic neuralgia.
|
J Control Release
|
2009
|
0.86
|
|
7
|
Transcutaneous sampling of ciprofloxacin and 8-methoxypsoralen by electroporation (ETS technique).
|
Int J Pharm
|
2008
|
0.85
|
|
8
|
Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis.
|
J Pharm Sci
|
2009
|
0.85
|
|
9
|
Upregulation of endogenous neurotrophin levels in the brain by intranasal administration of carnosic acid.
|
J Pharm Sci
|
2011
|
0.84
|
|
10
|
Transdermal drug delivery enhanced by low voltage electropulsation (LVE).
|
Pharm Dev Technol
|
2009
|
0.83
|
|
11
|
Alteration of the diffusional barrier property of the nail leads to greater terbinafine drug loading and permeation.
|
Int J Pharm
|
2009
|
0.83
|
|
12
|
Constant voltage 'Iron'tophoresis.
|
Pharm Dev Technol
|
2010
|
0.82
|
|
13
|
Delivery of nerve growth factor to brain via intranasal administration and enhancement of brain uptake.
|
J Pharm Sci
|
2009
|
0.81
|
|
14
|
"ChilDrive": a technique of combining regional cutaneous hypothermia with iontophoresis for the delivery of drugs to synovial fluid.
|
Pharm Res
|
2009
|
0.81
|
|
15
|
Transungual delivery of terbinafine by iontophoresis in onychomycotic nails.
|
Drug Dev Ind Pharm
|
2011
|
0.80
|
|
16
|
Iontophoresis across the proximal nail fold to target drugs to the nail matrix.
|
J Pharm Sci
|
2012
|
0.80
|
|
17
|
Microporation and 'iron'tophoresis for treating iron deficiency anemia.
|
Pharm Res
|
2012
|
0.79
|
|
18
|
Electroporation and transcutaneous sampling (ETS) of acyclovir.
|
J Dermatol Sci
|
2007
|
0.79
|
|
19
|
Formulation and evaluation of carnosic acid nanoparticulate system for upregulation of neurotrophins in the brain upon intranasal administration.
|
J Drug Target
|
2012
|
0.79
|
|
20
|
Effect of polyethylene glycols on the trans-ungual delivery of terbinafine.
|
Curr Drug Deliv
|
2010
|
0.77
|
|
21
|
Dermal drug levels of antibiotic (cephalexin) determined by electroporation and transcutaneous sampling (ETS) technique.
|
J Pharm Sci
|
2009
|
0.77
|
|
22
|
Iontophoretic drug delivery for the treatment of scars.
|
J Pharm Sci
|
2014
|
0.77
|
|
23
|
Delivery of cefotaxime to the brain via intranasal administration.
|
Drug Dev Ind Pharm
|
2011
|
0.77
|
|
24
|
An ex vivo toe model used to assess applicators for the iontophoretic ungual delivery of terbinafine.
|
Pharm Res
|
2009
|
0.77
|
|
25
|
Enhancement of nose-brain delivery of therapeutic agents for treating neurodegenerative diseases using peppermint oil.
|
Pharmazie
|
2010
|
0.76
|
|
26
|
Bilayered nail lacquer of terbinafine hydrochloride for treatment of onychomycosis.
|
J Pharm Sci
|
2010
|
0.76
|
|
27
|
Trans-ungual delivery of itraconazole hydrochloride by iontophoresis.
|
Drug Dev Ind Pharm
|
2014
|
0.75
|
|
28
|
In vitro and in vivo evaluation of a hydrogel-based prototype transdermal patch system of alfuzosin hydrochloride.
|
Pharm Dev Technol
|
2010
|
0.75
|
|
29
|
Albumin microspheres for oral delivery of iron.
|
J Drug Target
|
2010
|
0.75
|
|
30
|
Pretreatment with skin permeability enhancers: importance of duration and composition on the delivery of diclofenac sodium.
|
J Pharm Sci
|
2014
|
0.75
|
|
31
|
Brain-derived neurotrophic factor response in vulnerable and resilient genetic lines in the chick anxiety-depression model.
|
Behav Brain Res
|
2013
|
0.75
|
|
32
|
Transdermal iontophoretic delivery of propofol: a general anaesthetic in the form of its phosphate salt.
|
J Pharm Sci
|
2012
|
0.75
|
|
33
|
Minimally invasive transdermal delivery of iron-dextran.
|
J Pharm Sci
|
2012
|
0.75
|
|
34
|
Controlled-release injectable containing terbinafine/PLGA microspheres for onychomycosis treatment.
|
J Pharm Sci
|
2014
|
0.75
|
|
35
|
Iontophoresis for treating nail diseases.
|
Ther Deliv
|
2013
|
0.75
|